LA
ONC

LVW Advisors’s BeOne Medicines Ltd ONC Stock Holding History

LVW Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$211K Sell
739
-19
-3% -$5.6K 0.02% 442
2026
Q1 		$225K Sell
758
-29
-4% -$9.39K 0.02% 387
2025
Q4 		$239K Sell
787
-165
-17% -$54K 0.02% 311
2025
Q3 		$324K Sell
952
-70
-7% -$21.3K 0.03% 265
2025
Q2 		$247K Sell
1,022
-7
-0.7% -$1.72K 0.03% 290
2025
Q1 		$280K Sell
1,029
-103
-9% -$24.1K 0.03% 245
2024
Q4 		$209K Buy
1,132
+131
+13% +$26.8K 0.03% 296
2024
Q3 		$225K Sell
1,001
-978
-49% -$176K 0.03% 284
2024
Q2 		$282K Buy
1,979
+22
+1% +$3.39K 0.04% 238
2024
Q1 		$306K Buy
1,957
+654
+50% +$105K 0.05% 229
2023
Q4 		$235K Sell
1,303
-188
-13% -$34K 0.04% 234
2023
Q3 		$268K Sell
1,491
-313
-17% -$61.9K 0.06% 185
2023
Q2 		$322K Sell
1,804
-15
-0.8% -$3.45K 0.06% 157
2023
Q1 		$392K Buy
1,819
+135
+8% +$32.4K 0.08% 161
2022
Q4 		$370K Buy
1,684
+85
+5% +$15.6K 0.08% 169
2022
Q3 		$216K Sell
1,599
-55
-3% -$9.45K 0.05% 204
2022
Q2 		$268K Sell
1,654
-71
-4% -$11.1K 0.05% 196
2022
Q1 		$325K Sell
1,725
-74
-4% -$15.7K 0.06% 185
2021
Q4 		$487K Sell
1,799
-193
-10% -$65.2K 0.08% 151
2021
Q3 		$723K Buy
1,992
+68
+4% +$22.2K 0.12% 122
2021
Q2 		$660K Buy
1,924
+22
+1% +$7.29K 0.12% 124
2021
Q1 		$662K Buy
1,902
+314
+20% +$104K 0.13% 119
2020
Q4 		$410K Buy
1,588
+351
+28% +$96.6K 0.08% 136
2020
Q3 		$354K Buy
+1,237
New +$291K 0.08% 138

Other funds holding ONC

AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
SC
Slow Capital Greenbrae, California $857M AUM 38.3% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

LVW Advisors's ONC Position: Q2 2026 in Review

LVW Advisors reduced its BeOne Medicines Ltd (ONC) stake by 2.5% in Q2 2026, selling an estimated $5.6K and leaving 739 shares worth $211K. The position accounts for 0.02% of the portfolio, ranked #442.

LVW Advisors first reported a position in ONC in Q3 2020 and has held it in 24 quarters since. The position peaked at $723K in Q3 2021. 66 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • LVW Advisors held 739 shares of BeOne Medicines Ltd worth $211K as of Q2 2026.
  • LVW Advisors sold 19 BeOne Medicines Ltd shares in Q2 2026, an estimated $5.6K.
  • BeOne Medicines Ltd made up 0.02% of LVW Advisors's portfolio in Q2 2026, its #442 holding.
  • LVW Advisors first reported a position in BeOne Medicines Ltd in Q3 2020 and has held it in 24 quarters since.
  • LVW Advisors's BeOne Medicines Ltd position peaked at $723K in Q3 2021.
  • 66 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on LVW Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.